Amphion Innovations (AMP)

 

Latest News

Amphion reduces stake in Motif Bio

Amphion Innovations has soled 1,700,000 shares in partner company, Motif Bio, in partial repayment of the loan facility or...

Holding(s) in Company

RNS Number: 2342P Motif Bio PLC 30 August 2017 30 August 2017 Motif Bio plc ("Motif" or the "Company") Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it was informed on 29 August 2017 by Amphion Innovations plc ("Amphion") that 1,700,000 ordinary shares in the Compa...

Sale of partner company shares

RNS Number: 2325P Amphion Innovations PLC 30 August 2017 Amphion Innovations plc ("Amphion" or "the Company") 30 August 2017 Sale of Partner Company Shares London and New York, Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that 1,700,000 shares in Partner Company, Motif ...

AGM Statement

RNS Number: 8103M Amphion Innovations PLC 01 August 2017 Amphion Innovations plc ("Amphion" or "the Company") 1 August 2017 Results of AGM London and New York, 1 August 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that all resolutions were passed at the Annual Gene...

All News

DateHeadlineSource
01-07-15Holding(s) in CompanyRNS
26-06-15Small-cap rockets: Double or quits?Interactive Investor
23-06-15Amphion partner company raises £22m StockMarketWire
23-06-15Partner Company raises £22 millionRNS
23-06-15Amphion pre-tax losses rise StockMarketWire
23-06-15Preliminary ResultsRNS
18-06-15Motif Bio's multi-billion dollar best-seller?Interactive Investor
05-06-15FTSE dips on retailers, miners as Tsipras probedStockMarketWire
05-06-15FTSE entrenches losses as VOD, retailers sourStockMarketWire
05-06-15Amphion raises £1.54m StockMarketWire
05-06-15Placing to raise £1.54 millionRNS
19-05-15Amphion appoints joint corporate broker StockMarketWire
19-05-15Appointment of brokerRNS
15-04-15Amphion partner get FDA go-ahead for iclaprim development StockMarketWire
15-04-15FDA ResultsRNS
07-04-15Amphion warrants exercised StockMarketWire
07-04-15Shares Issued for Exercised WarrantsRNS
02-04-15Amphion partner Motif floats on AIM StockMarketWire
02-04-15First Day of Dealings of Amphion Partner CompanyRNS
24-03-15Issue of SharesRNS
20-03-15Amphion partner Motif to float on AIM StockMarketWire
20-03-15Motif Bio Ltd Update Re Intention to FloatRNS
26-02-15Issue of EquityRNS
09-02-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
09-02-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
09-02-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
09-02-15Director/PDMR ShareholdingRNS
02-02-15Reissue: Partner Company's Intention to FloatRNS
02-02-15Interesting trio bid to IPO on AIMInteractive Investor
02-02-15Amphion partner company to float on AIM StockMarketWire
02-02-15Partner Company's Intention to Float on AIMRNS
22-01-15Director/PDMR ShareholdingRNS
19-01-15Amphion partner company in acquisition StockMarketWire
19-01-15Amphion partner company in acquisition StockMarketWire
19-01-15Landmark Acquisition & Update by Partner CompanyRNS
06-01-15FTSE sorties lower as Wall St falters on oil worriesStockMarketWire
06-01-15Why Amphion Innovations is up 200%Interactive Investor
06-01-15FTSE limps south as oil price slide sparks sell-offStockMarketWire
06-01-15Amphion's winStockMarketWire
06-01-15DataTern Receives Favourable Appeal RulingRNS

RSS feeds

  • Editorial news feed for LSE:AMP Editorial
  • Regulatory news feed for LSE:AMP Regulatory